Spartan Fund Management’s Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 LHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-55,245
Closed -$1K 552
2022
Q3
$1K Hold
55,245
﹤0.01% 424
2022
Q2
$5K Hold
55,245
﹤0.01% 427
2022
Q1
$23K Buy
+55,245
New +$27.1K ﹤0.01% 383

Other funds holding LHC.WS

Spartan Fund Management's LHC.WS Position: Q4 2022 in Review

Spartan Fund Management sold out of Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (LHC.WS) in Q4 2022, closing a stake of 55,245 shares — an estimated $1K sold.

Spartan Fund Management first reported a position in LHC.WS in Q1 2022 and held it in 3 quarters. The position peaked at $23K in Q1 2022. 7 funds tracked by Wall St. Rank hold LHC.WS as of Q4 2022.

  • Spartan Fund Management reported no remaining Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Spartan Fund Management sold 55,245 Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022, an estimated $1K.
  • Spartan Fund Management first reported a position in Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 3 quarters.
  • Spartan Fund Management's Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $23K in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on Spartan Fund Management's 13F filing for Q4 2022, filed 24 Jan 2023.